IDEAS home Printed from https://ideas.repec.org/p/zbw/udewwd/225.html
   My bibliography  Save this paper

Anpassung von AMNOG-Preisfaktoren im Zeitverlauf - Eine Analyse mit Fokus auf das Kriterium der europäischen Vergleichspreise: Gutachten für die Bristol-Myers Squibb GmbH & Co. KGaA

Author

Listed:
  • Bauer, Cosima
  • May, Uwe

Abstract

Das vorliegende Gutachten adressiert ökonomische und pharmapolitische Fragestellungen im Zusammenhang mit der Referenzierung auf europäische Arzneimittelpreise bei der Festsetzung von Erstattungsbeträgen gemäß des Arzneimittelmarktneuordnungsgesetzes (AMNOG). Wir danken dem Vorsitzenden der AMONG-Schiedsstelle, Prof. Dr. Jürgen Wasem, für kritische Kommentare und wertvolle Anregungen zu einem Vorentwurf des vorliegenden Discussion Papers. Die Beschreibung der Ausgangssituation umfasst eine kurze Darstellung des Projekthintergrunds, die Ableitung der Untersuchungsfragen sowie eine Skizzierung des methodischen Vorgehens.

Suggested Citation

  • Bauer, Cosima & May, Uwe, 2019. "Anpassung von AMNOG-Preisfaktoren im Zeitverlauf - Eine Analyse mit Fokus auf das Kriterium der europäischen Vergleichspreise: Gutachten für die Bristol-Myers Squibb GmbH & Co. KGaA," IBES Diskussionsbeiträge 225, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    • Handle: RePEc:zbw:udewwd:225
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/195191/1/1662939620.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Bauer, Cosima & May, Uwe & Wasem, Jürgen, 2016. "Analyse und Beschreibung des AMNOG-Umsetzungsproblems in die Versorgungspraxis," IBES Diskussionsbeiträge 216, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    2. Weegen, Lennart & May, Uwe & Bauer, Cosima & Walendzik, Anke & Wasem, Jürgen, 2016. "Umsetzung des AMNOG in die Versorgungspraxis," IBES Diskussionsbeiträge 217, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    3. Mahlich Jörg & Sindern Jörn & Suppliet Moritz, 2015. "Vergleichbarkeit internationaler Arzneimittelpreise," Perspektiven der Wirtschaftspolitik, De Gruyter, vol. 16(2), pages 164-172, June.
    4. Afschin Gandjour, 2013. "Reference Pricing and Price Negotiations for Innovative New Drugs," PharmacoEconomics, Springer, vol. 31(1), pages 11-14, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Giulini-Limbach, Chiara & Bauer, Cosima & May, Uwe, 2021. "Arzneimittelmarkt-Steuerung unter dem Einfluss von AMNOG und Festbeträgen: Forschungsprojekt im Auftrag der Bristol-Myers Squibb GmbH & Co. KGaA," IBES Diskussionsbeiträge 232, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Tunder, Ralph & Martschinke, Belinda, 2016. "Die Beurteilung des Arzneimittelmarkt-Neuordnungsgesetzes (AMNOG) aus Sicht der gesetzlichen Krankenkassen," EconStor Preprints 130542, ZBW - Leibniz Information Centre for Economics.
    2. Bauer, Cosima & May, Uwe, 2017. "Adäquate Preisbildung bei neuen Anwendungsgebieten AMNOG-bewerteter Arzneimittel: Projektbericht für die Bristol-Myers Squibb GmbH & Co. KGaA," IBES Diskussionsbeiträge 222, University of Duisburg-Essen, Institute of Business and Economic Studie (IBES).
    3. Kanavos, Panos, 2019. "Does external reference pricing deliver what it promises? Evidence on its impact at national level," LSE Research Online Documents on Economics 101522, London School of Economics and Political Science, LSE Library.
    4. Jennifer Gill & Anna-Maria Fontrier & Dionysis Kyriopoulos & Panos Kanavos, 2019. "Variations in external reference pricing implementation: does it matter for public policy?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1375-1397, December.
    5. Panos Kanavos & Anna-Maria Fontrier & Jennifer Gill & Olina Efthymiadou, 2020. "Does external reference pricing deliver what it promises? Evidence on its impact at national level," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 129-151, February.
    6. Kwon, Hye-Young & Kim, Jinhyun, 2020. "Consistency of new drug pricing in Korea: Bridging variations among personnel in price negotiations," Health Policy, Elsevier, vol. 124(9), pages 965-970.

    More about this item

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:udewwd:225. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/fwessde.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.